Sweetch

Company Overview

Snapshot

Founded in October 2013 by Yossi Bahagon and Keren Shavit, Sweetch operates with 51–200 employees. The company has raised $44.8 million across 7 disclosed funding rounds from 15 investors.

Business overview

Sweetch develops an AI-powered hyper-personalized patient engagement platform that merges artificial intelligence with behavioral science to help patients manage chronic conditions. The platform leverages data from smartphones and connected devices to deliver real-time, tailored recommendations. Its proprietary Just-in-Time-Adaptive-Intervention (JITAI) technology continuously analyzes patient context and behavior patterns to fine-tune interactions, serving healthcare organizations, pharma companies, insurers, and healthcare providers.

Strategic signal

In November 2022, Sweetch strengthened its advisory board with the appointment of Dr. Fatima Cody Stanford, an obesity medicine expert. This strategic addition enhances Sweetch's capabilities in implementing advanced obesity management practices, signaling a focused expansion into addressing the growing global prevalence of obesity through its hyper-personalized engagement solutions.

Company Intelligence Q&A

What strategic update did Sweetch announce in October 2022?

In October 2022, Sweetch launched Sweetch 2.0, an updated platform designed to revolutionize patient partnership in chronic disease management. This version integrates AI and emotional intelligence technology with a consumer-app style interface to enhance patient engagement and adherence to treatment regimens.

What was a key partnership for Sweetch in 2021?

In September 2021, Sweetch entered a strategic partnership with Grupo Fleury, one of Brazil's leading healthcare providers. This collaboration aimed to integrate Sweetch's platform into Fleury's Saúde iD telemedicine services to improve outcomes for patients with chronic conditions, initially focusing on obesity, pre-diabetes, and Type 2 diabetes.

What was the outcome of Sweetch's Series A funding round in July 2021?

In July 2021, Sweetch completed a Series A funding round led by Entrée Capital and joined by Tal Ventures, among others. The funds were allocated for global expansion and further development of its AI and emotional intelligence behavioral science technology for chronic disease management.